- Published at
- by seekingalpha.com
neutral
neutral
Rapid Micro Biosystems: Benefiting From Partnership With Merck; Initiating With 'Buy' (NASDAQ:RPID)
Initiating Rapid Micro Biosystems at 'buy' with $4.60 fair value, driven by strong growth potential in automated microbial quality control market.